Issued Patents All Time
Showing 26–50 of 360 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 9040728 | Crystallization of (20R) 19-nor-24-difluoro-1α,25-dihydroxyvitamin D3 | Agnieszka Flores, James B. Thoden, Hazel Holden | 2015-05-26 |
| 9034853 | Use of 2-methylene-19-nor-(20S)-1α,25-dihydroxyvitamin D3 to treat secondary hyperparathyroidism | Julia B. Zella, Lori A. Plum, Margaret Clagett-Dame | 2015-05-19 |
| 8993547 | 3-desoxy-2-methylene-19-nor-vitamin D analogs and their uses | Lori A. Plum, Rafal R. Sicinski, Izabela Sibilska, Margaret Clagett-Dame | 2015-03-31 |
| 8987235 | N-cyclopropyl-(20R)-2-methylene-19,26,27-trinor-25-aza-vitamin D analogs and their uses | Margaret Clagett-Dame, Lori A. Plum, Grazia Chiellini | 2015-03-24 |
| 8940916 | Crystallization of (20R)-2-methylene-19-nor-24-difluoro-1α,25-dihydroxyvitamin D3 | Agnieszka Flores, James B. Thoden, Hazel Holden | 2015-01-27 |
| 8884039 | Crystallization of (20R) and (20S) analogs of 2-methylene-19-nor-24-dimethyl-1α,25-dihydroxyvitamin D3 | Agnieszka Flores, James B. Thoden, Hazel Holden | 2014-11-11 |
| 8785422 | A-ring modified 19-nor-vitamin D analogs and their uses | Margaret Clagett-Dame, Lori A. Plum, Agnieszka Glebocka | 2014-07-22 |
| 8759328 | Once-a-week administration of 25-hydroxy vitamin D3 to sustain elevated steady-state pharmacokinetic blood concentration | Lori A. Plum, Margaret Clagett-Dame | 2014-06-24 |
| 8754067 | 22-haloacetoxy-homopregnacalciferol analogs and their uses | Rafal Barycki, Lori A. Plum | 2014-06-17 |
| 8729054 | 3-desoxy-2-methylene-vitamin D analogs and their uses | Lori A. Plum, Rafal R. Sicinski, Izabela Sibilska | 2014-05-20 |
| 8664206 | Diastereomers of 2-methylene-19-nor-22-methyl-1α,25-dihydroxyvitamin D3 | Agnieszka Flores, Pawel Grzywacz, Lori A. Plum, Margaret Clagett-Dame, James B. Thoden +1 more | 2014-03-04 |
| 8642579 | 1-desoxy-2-methylene-19-nor-vitamin D analogs and their uses | Katarzyna M. Barycka, Izabela Sibilska, Lori A. Plum, Margaret Clagett-Dame, Rafal Barycki +2 more | 2014-02-04 |
| 8614202 | 2α-methyl and 2β-methyl analogs of 19,26,27-trinor-(20S)-1α-hydroxyvitamin D3 and their uses | Lori A. Plum, Pawel Grzywacz, Margaret Clagett-Dame | 2013-12-24 |
| 8609643 | 2-methylene-(20S,25R)-19,26-dinor-vitamin D analogs | Margaret Clagett-Dame, Lori A. Plum, Grazia Chiellini, Pawel Grzywacz | 2013-12-17 |
| 8604009 | (20S)-2-methylene-19-nor-22-dimethyl-1α,25-dihydroxyvitamin D3 and (20R)-2-methylene-19-nor-22-dimethyl-1α,25-hydroxyvitamin D3 | Agnieszka Flores, Pawel Grzywacz, Lori A. Plum, Margaret Clagett-Dame | 2013-12-10 |
| 8604008 | 2-methylene-19,21-dinor-1α-hydroxy-bishomopregnacalciferol | Lori A. Plum, Margaret Clagett-Dame | 2013-12-10 |
| 8575136 | 2-methylene-1α-hydroxy-18,19,21-trinorvitamin D3 analogs and uses thereof | Lori A. Plum, Margaret Clagett-Dame, Rafal Barycki | 2013-11-05 |
| 8519169 | Crystallization a 1alpha-hydroxy-20-methyl-2-methylene-19,24,25,26,27-pentanorvitamin D3 | Agnieszka Glebocka, James B. Thoden, Hazel Holden | 2013-08-27 |
| 8518917 | 2-methylene-19-nor-vitamin D analogs and their uses | Izabela Sibliska, Lori A. Plum, Margaret Clagett-Dame, Rafal R. Sicinski, Katarzyna M. Barycka +2 more | 2013-08-27 |
| 8455467 | 2-methylene-vitamin D analogs and their uses | Lori A. Plum, Rafal R. Sicinski, Izabela Sibilska | 2013-06-04 |
| 8445468 | (20S,22E)-2-methylene-19-nor-22-ene-1α,25-dihydroxyvitamin D3 | Pawel Grzywacz, Lori A. Plum, Margaret Clagett-Dame | 2013-05-21 |
| 8440647 | 2α-methyl and 2β-methyl analogs of 19,26,27-trinor-(20S)-1α-hydroxyvitamin D3 and their uses | Lori A. Plum, Pawel Grzywacz, Margaret Clagett-Dame | 2013-05-14 |
| 8420839 | Crystallization of 1α-hydroxy-2-methylene-18,19-dinor-homopregnacalciferol | Rafal Barycki, James B. Thoden, Hazel Holden | 2013-04-16 |
| 8410080 | 2-methylene-vitamin D analogs and their uses | Lori A. Plum, Rafal R. Sicinski, Izabela Sibilska | 2013-04-02 |
| 8404874 | (20R,25S)-2-Methylene-19,26-Dinor-1α,25-Dihydroxyvitamin D3 in crystalline form | Pawel Grzywacz, James B. Thoden, Hazel Holden | 2013-03-26 |